Adjuvant chemotherapy for stage II colon cancer: Practice patterns and effectiveness in the general population

被引：0
|
作者：
Booth, Christopher M.
Nanji, Sulaiman
Wei, Xuejiao
Peng, Yingwei
Biagi, James Joseph
Hanna, Timothy P.
Krzyzanowska, Monika K.
Mackillop, William J.
机构：
[1] Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON, Canada
[2] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[3] Queens Univ, Canc Res Inst, Kingston, ON, Canada
[4] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6569
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Adjuvant chemotherapy of stage III colon cancer
    Benson, AB
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S74 - S77
  • [42] Adjuvant Chemotherapy for Stage III Colon Cancer
    Taieb, Julien
    Gallois, Claire
    CANCERS, 2020, 12 (09) : 1 - 17
  • [43] Early evaluation of effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
    Kramer, A.
    Greuter, M. J.
    Schraa, S.
    Vink, G. R.
    Phallen, J.
    Velculescu, V.
    Meijer, G.
    Van den Broek, D.
    Koopman, M.
    Roodhart, J. M. L.
    Fijneman, R.
    Retel, V. P.
    Coupe, V.
    ANNALS OF ONCOLOGY, 2023, 34 : S247 - S247
  • [44] MODEL-BASED EFFECTIVENESS AND COST-EFFECTIVENESS OF PERSONALIZED SELECTION STRATEGIES FOR ADJUVANT CHEMOTHERAPY IN STAGE II COLON CANCER
    Jongeneel, Gabrielle
    Greuter, Marjolein J. E.
    van Erning, Felice N.
    Koopman, Miriam
    Vink, Geraldine R.
    Punt, Cornelis J. A.
    Coupe, Veerle M. H.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E80 - E81
  • [45] Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
    Kramer, Astrid
    Greuter, Marjolein J. E.
    Schraa, Suzanna J.
    Vink, Geraldine R.
    Phallen, Jillian
    Velculescu, Victor E.
    Meijer, Gerrit A.
    van den Broek, Daan
    Koopman, Miriam
    Roodhart, Jeanine M. L.
    Fijneman, Remond J. A.
    Retel, Valesca P.
    Coupe, Veerle M. H.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [46] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [47] Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer after Complete Resection: An Updated Practice Guideline
    Jonker, D. J.
    Spithoff, K.
    Maroun, J.
    CLINICAL ONCOLOGY, 2011, 23 (05) : 314 - 322
  • [48] Adjuvant treatment of stage II colon cancer: Is there a true no-chemotherapy group?
    Martin, Robert C. G.
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (06) : 766 - 767
  • [49] Adjuvant chemotherapy guided by circulating tumour DNA in stage II colon cancer
    Ray, Katrina
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (08) : 488 - 488
  • [50] Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer
    Hagerty, Brendan L.
    Aversa, John G.
    Dominguez, Dana A.
    Davis, Jeremy L.
    Hernandez, Jonathan M.
    McCormick, James T.
    Blakely, Andrew M.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (10) : 1206 - 1214
12345